66
Views
14
CrossRef citations to date
0
Altmetric
Brief reports

Rectal Cell-Associated HIV-1 RNA: A New Marker Ready for the Clinic

, , , , , & show all
Pages 324-327 | Published online: 06 Jan 2015

REFERENCES

  • Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature. 2005;434:1093–1097.
  • Guadalupe M, Sankaran S, George MD, et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infec-tion. J ViroL 2006;80: 8236–8247.
  • Chun TW, Nickle DC, Justement JS, et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis. 2008;197:714–720.
  • Avettand-Fenoel V, Prazuck T, Hocqueloux L, et al. HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors. AIDS. 2008;22(14)1880–1882.
  • Dinoso JB, Kim SY, Wiegand AM, et al. Treatment intensi-fication does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci USA. 2009;106(23):9403–9408.
  • Médecine - Sciences Flammarion, Ed. Rapport Yet-1i 2008. Prise en charge médicale des personnes infectées par le VIH-1. Recommandations du groupe d'experts. pp. 322–323. ISBN 978-2-2570-0062–0.
  • Palmer S, Wiegand AP, Maldarelli F, et al. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 2003;41:4531–4536.
  • Shen L, Siliciano RF. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral ther-apy to eradicate HIV infection. J Allergy Clin Immunol. 2008;122(1):22–28.
  • Poles MA, Boscardin WJ, Elliott J, et al. Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals. J Acquir Immune Defic Syndr 2006;43(1):65–68.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.